Connect with us

Technology

Olympus Announces Launch of AI-Powered Surgical Planning Tool Through Strategic Partnership with Ziosoft

Published

on

Olympus Will Highlight the Platform at Annual SAGES Meeting

CENTER VALLEY, Pa., March 12, 2025 /PRNewswire/ — Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the launch of its first AI-powered clinical decision tool through a strategic partnership with software firm, Ziosoft.

The application integrates advanced imaging analytics and machine learning, empowering surgeons to take ownership of their pre-op planning. This collaboration represents a significant step forward in Olympus’s mission to bring innovative, AI-enabled solutions to the healthcare industry to help make clinical workflows more efficient and effective.

The first three applications being launched aim to revolutionize liver, lung, and kidney procedures:

Thoracic surgery: Transforms 2D CT/MRI images into precise 3D models, aiding in lung cancer and thoracic procedure planning and reducing invasive approaches.Liver surgery: Helps general and hepatobiliary surgeons visualize liver anatomy, practice ahead and plan liver-sparing surgeries by visualizing vessels and tumors, helping to improve patient recovery.Urologic surgery: Assists in minimally invasive nephrectomies by accurately assessing the size, location and shape of tumors, cysts or other abnormalities.

Olympus will highlight the Ziosoft Revoras platform during the annual Society of Gastrointestinal and Endoscopic Surgeons (SAGES) meeting March 12-15 in Long Beach, Calif.

“Olympus has a proud legacy in medical technology, particularly as a pioneer in endoscopy. We are excited to partner with Ziosoft, which has its own long history of developing AI software to help physicians make more accurate diagnostic and treatment decisions during procedures,” said Darryl Rock, Vice President, Business Unit Leader, Surgical Solutions. “This collaboration represents a significant step forward in Olympus’s mission to bring innovative, AI-enabled solutions to the healthcare industry.”

Physicians traditionally utilized flat, 2D images to plan procedures. This new application uses imaging such as CT scans and MRIs to translate static images into dynamic 3D modeling in real time utilizing AI and thousands of radiologic images. The aim is to help physicians make better clinical decisions in sparing as much tissue as possible and improve tumor margins.

The development of 3D procedure modeling can also help educate surgical fellows and help guide newer surgeons through unfamiliar procedures and workflow. This supports Olympus’ commitment to enhancing surgical outcomes with AI-powered clinical decision support applications. It marks the first in a series of surgical innovations aimed at “Seeing the Invisible” designed to make procedures safer, more efficient and consistently successful.

“Ziosoft is committed to improving patient outcomes, and we are pleased to collaborate with Olympus to equip clinicians with greater diagnostic capabilities through advanced visualization,” said Rajeev Taitriya, Vice President, Business Development and Marketing, Ziosoft. “By combining our expertise in AI-driven imaging with Olympus’ leadership in minimally invasive treatment solutions, we can help enhance surgical precision and streamline workflows, ultimately improving patient care. With the rise of lung cancer screening, more patients are undergoing complex segmentectomies, which Ziosoft’s REVORAS platform can support by enabling rapid pre-operative planning, allowing thoracic surgeons to make critical surgical decisions in minutes, helping to optimize outcomes and advance the standard of care.”

This surgical planning application will be launched in parallel to the Olympus’ Intelligent Endoscopy Ecosystem, which looks to leverage technologies like AI and integrate hardware, software, services and data to enhance clinical decision-making and streamline workflows in GI.

During the SAGES annual meeting, Olympus will also highlight its surgical portfolio, including their multispecialty imaging platform and the ESG-410™ Surgical Energy Platform that powers a comprehensive energy solution with applications across numerous specialties such as general surgery, thoracic surgery, urology and gynecology.

Olympus will feature its EVIS X1™ Endoscopy System and CADDIE™ AI System, the first cloud-based AI endoscopy system designed to assist gastroenterologists and colorectal surgeons in detecting suspected colorectal polyps during colonoscopy procedures and localizing disease during surgical procedures.

The CADDIE device works by analyzing the endoscopic video of the colon in real-time and using visual markers to alert the endoscopist or surgeon to the potential presence of polyps. The endoscopist or surgeon is responsible for reviewing the CADDIE device’s suspected polyp areas and confirming the presence or absence of a polyp based on their own medical judgment.

For more information about Ziosoft or the Olympus surgical portfolio visit the Olympus booth, #749, during SAGES, or visit the Olympus website.

About Olympus
At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.

For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world.

Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America. For more information, visit medical.olympusamerica.com.

About Ziosoft
Founded in 1998 with offices in Japan and U.S., Ziosoft is a recognized leader in functional CT/MRI 3D visualization and analysis software to benefit physicians, patients and healthcare specialists. With thousands of systems installed in more than 30 countries worldwide and 900 scientific publications, Ziosoft’s true vendor-neutral and multi-modality advanced visualization technology platform is helping patients and clinicians every day, by helping to enable greater diagnostic confidence, lower dose options and precision in treatment planning. As a software-only solution, it is simplified to minimize cost of ownership. For further information on Ziosoft, visit ziosoftinc.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/olympus-announces-launch-of-ai-powered-surgical-planning-tool-through-strategic-partnership-with-ziosoft-302400208.html

SOURCE Olympus Corporation of the Americas

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MasonMade Ventures Founded to Transform Facilities Management

Published

on

By

Serial Entrepreneurs Launch Firm to Disrupt FM Industry through Software Solutions and Highly Technical Trades

NEW YORK, March 19, 2025 /PRNewswire/ — Serial entrepreneurs Joseph Scaretta and Moses Carrasco announce the launch of MasonMade Ventures, an operational holding company that invests in, acquires, and expands critical infrastructure businesses. The firm’s investment strategy aims to solve complex industry gaps with a focus on software solutions and highly technical infrastructure trades in underserved markets such as fire suppression, material handling and vertical transportation. 

“Our firm is built by founders for founders, together solving gaps within our industry,” Co-CEO, Joseph Scaretta, said.

MasonMade offers a unique co-CEO model that pairs industry experts with operations and business development specialists, providing portfolio companies with the autonomy to operate independently while benefiting from strategic guidance, operational efficiencies, and scalable growth opportunities. As self-made entrepreneurs with two successful private-equity exits, Scaretta and Carrasco believe in a people-first culture where the investors actively support leadership teams by strengthening core capabilities while supplementing with complimentary skills.

“At MasonMade, we are dedicated to creating an environment where the businesses we serve can thrive,” Carrasco, Co-CEO and founder, said. “We will be partners in the growth of each company in our portfolio – to empower and enable facilities management entrepreneurs who have built their own companies from the ground up.”

MasonMade is not your average holding company. It is founded on a legacy of success and with the entrepreneurial vision of Scaretta and Carrasco who have been pushing boundaries since they first joined the facilities management industry in 2003 with their start-up Empire Facilities.

“Our firm is built by founders for founders, together solving gaps within our industry,” Scaretta, who serves as Co-CEO and founder, added. “We are back to disrupt the facilities management industry once again by driving sustainable growth in our portfolio companies while setting new standards of excellence to shape the future of the industry.”

MasonMade offers extensive industry expertise, strategic financial guidance, and a people-first approach. The leadership team’s dedication to fostering a people-first culture was reflected by multiple appearances on the Inc. 5000 list. Their commitment to making a lasting social impact is evidenced through philanthropic initiatives including Pop Ups for Good and the Young Entrepreneur Challenge, which will be relaunched in 2026.

The team at MasonMade Ventures is strengthened by the leadership of Desiree Russo and Rob Baird. Russo, who has 20 years of operational experience and innovative leadership in facilities management, is a Partner and will serve as Senior Vice President of Portfolio Operations. Baird, who specializes in optimizing financial structures and driving operational efficiencies, is also a Partner and will serve as Chief Financial Officer.

For more information about MasonMade Ventures, please visit MasonMade.co.

About MasonMade Ventures
MasonMade Ventures is an operational holding company founded by Joseph Scaretta and Moses Carrasco. The firm focuses on investing in and expanding businesses that provide critical infrastructure support services. With a people-first philosophy, forward-looking vision, commitment to operational excellence and dedication to entrepreneurial success, MasonMade is redefining the facilities management industry.

Media Inquiries:
Joseph Scaretta
Co-CEO & Founder
MasonMade Ventures
media@masonmade.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/masonmade-ventures-founded-to-transform-facilities-management-302405736.html

SOURCE MasonMade Ventures

Continue Reading

Technology

Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic Phlebotomy

Published

on

By

Collaboration to Address Global Staffing Shortages and Set a New Standard for Automated Diagnostic Blood Collection

CHICAGO and SAN FRANCISCO, March 19, 2025 /PRNewswire/ — Northwestern Medicine, Chicago’s premier integrated academic health system, and Vitestro, a pioneer in autonomous robotic vascular access and diagnostic blood collection, today announced a multi-year collaboration to advance automation in phlebotomy and transform the patient experience.

As part of this collaboration, Northwestern Medicine will participate in a multicenter clinical trial validating the performance and safety of Vitestro’s Aletta™—the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). The goal of the study is to generate key clinical evidence to support adoption of automated phlebotomy as a scalable solution for U.S. hospital and outpatient blood draw centers.

“At Northwestern Medicine, we are dedicated to pioneering innovations that elevate patient care and operational excellence,” said Gary A. Noskin, MD, senior vice president, Northwestern Memorial HealthCare, and president, Northwestern Medical Group. “Our collaboration with Vitestro is a step forward in transforming diagnostic testing by automating venous blood collection. Through this relationship our goal is to improve efficiency, enhance sample integrity, and redefine the patient experience through cutting-edge technology.”

By automating and standardizing blood collection, this collaboration aims to:

Address critical phlebotomy workforce shortages by providing a scalable, automated solution.Enhance operational efficiency and patient throughput in high-volume hospital outpatient settings.Improve sample quality and integrity, reducing errors associated with manual venipuncture.Expand access to high-quality blood collection while enhancing patient comfort and overall care.

“We are privileged to collaborate with Northwestern Medicine in setting a new standard for laboratory automation,” said Brian Joseph, Co-founder of Vitestro. “Vitestro’s mission is to empower hospitals and laboratories with transformative robotic solutions that drive efficiency, improve clinical outcomes, and elevate the patient experience. This collaboration will further validate the role of automation in modernizing blood collection.”

As Chicago’s premier integrated academic health system, Northwestern Medicine offers patients access to world class, compassionate care at 11 hospitals and more than 200 diagnostic and ambulatory sites.

“Phlebotomy remains one of the last manual processes in laboratory medicine, and automation presents a pivotal opportunity to transform it,” said Gregory S. Retzinger, MD, PhD, Medical Director of Pathology Clinical Services, Northwestern Memorial Hospital. “This collaboration goes beyond evaluating autonomous robotic phlebotomy — it has the potential to solve urgent staffing challenges and redefining the future of laboratory medicine.

“We are proud to partner with Northwestern Medicine’s visionary leadership, who recognize the future in phlebotomy automation,” said Bob Gerberich, CCO of North America at Vitestro. “Their commitment, along with the work of our other U.S. clinical trial partners, will be instrumental in establishing a new standard in total laboratory workflow automation. This collaboration marks a defining moment in making autonomous blood collection an integral part of modern healthcare.”

About Northwestern Medicine
To learn more about Northwestern Medicine, please visit NM.org.

About Vitestro
Vitestro is a global leader in medical robotics, headquartered in the Netherlands, with deep expertise in engineering, robotics, and commercialization in both the U.S. and international markets. The company has developed and launched the world’s first and only CE-marked Autonomous Robotic Phlebotomy Device™ (ARPD™), setting a new benchmark for diagnostic venous blood sampling. By integrating advanced robotics, artificial intelligence, and imaging technology, Vitestro delivers precision, efficiency, and an enhanced patient experience. While Aletta has not yet received FDA approval, Vitestro is actively preparing for regulatory approval in the U.S. and global expansion.

For more information, visit vitestro.com. 

View original content:https://www.prnewswire.co.uk/news-releases/northwestern-medicine-and-vitestro-collaborate-to-advance-autonomous-robotic-phlebotomy-302404767.html

Continue Reading

Technology

Capital Credit Union Modernizes Operations and Positions for Growth with Jack Henry

Published

on

By

Credit union selects Jack Henry for long-term stability and support

MONETT, Mo., March 19, 2025 /PRNewswire/ — Jack Henry™ (Nasdaq: JKHY) is pleased to announce that Capital Credit Union converted to Jack Henry’s Symitar® platform and complementary products to support its future growth. 

The credit union dates back to 1936, founded by state employees meeting in the North Dakota Capitol building with a mission to support financial well-being and provide reliable credit. Over the years, the credit union flourished, through organic growth and mergers to expand its reach and impact. Today, Capital Credit Union has over $800 million in assets, and it remains dedicated to supporting the financial success of its more than 32,000 members.

After experiencing eightfold growth in 18 years, the credit union’s existing core platform could no longer support its long-term growth objectives. It was crucial for Capital to find a provider that could enhance support and service while also positioning them to meet increased demands related to security and data encryption. The institution was impressed by Jack Henry’s strong reputation as the largest core provider for credit unions over $1 billion in assets and a leader in the $250 million to $1 billion asset segment. Capital Credit Union also valued Jack Henry’s dedication to, and reputation for, exceptional customer service and support.

“Our decision to convert to Jack Henry is an investment in the future of our organization and members,” said Kurt Schmidt, Chief Information Officer of Capital Credit Union. “We’re pleased with how thorough, responsive, and efficient the Jack Henry team has been, both from a technical and training perspective. While it’s still relatively early for us in the conversion process, Jack Henry’s user-friendly experience will empower more employees to work directly with the technology in areas important to us. This should help us with competitive differentiators while helping us free up resources that can be used to offer even stronger member benefits and service.”

The credit union moved to an outsourced core model, trusting Jack Henry’s comprehensive, broad-based system to maintain its technology while enabling employees to focus on meaningful differentiators and member service. For example, they’ve worked on increasing member security from a holistic perspective, along with additional workflow solutions and advanced reporting capabilities to improve their member experiences. By consolidating under one vendor, they gained integrated solutions and streamlined support, helping their technology and teams work more efficiently together. 

“We appreciate when credit unions like Capital Credit Union choose us for our innovation and service, which have been core to both our culture and success,” added Brynn Ammon, President of Credit Union Solutions at Jack Henry. “Capital Credit Union has been a cornerstone of its community for 90 years, and we are honored to be the technology provider of choice to help them continue that legacy.”

About Jack Henry & Associates, Inc.® 
Jack Henry™ (Nasdaq: JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions and the people and businesses they serve. We are an S&P 500 company that prioritizes openness, collaboration, and user centricity – offering banks and credit unions a vibrant ecosystem of internally developed modern capabilities as well as the ability to integrate with leading fintechs. For more than 48 years, Jack Henry has provided technology solutions to enable clients to innovate faster, strategically differentiate, and successfully compete while serving the evolving needs of their accountholders. We empower approximately 7,500 clients with people-inspired innovation, personal service, and insight-driven solutions that help reduce the barriers to financial health. Additional information is available at www.jackhenry.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/capital-credit-union-modernizes-operations-and-positions-for-growth-with-jack-henry-302402866.html

SOURCE Jack Henry & Associates, Inc.

Continue Reading

Trending